C. Pañella

1.6k citations

47 papers · 1.2k indexed · h-index 20

Impact in

Gastroenterology top 2%
- Gastroesophageal reflux and treatments
Small Animals top 1%
- Veterinary medicine and infectious diseases

Papers in ⓘ

Gastroenterology 6
- Gastroesophageal reflux and treatments 5
Small Animals 5
- Veterinary medicine and infectious diseases 5

Co-authors: Enzo Ierardi (25 shared papers)Angelo Zullo (12 shared papers)S. Morini (11 shared papers)Cesare Hassan (11 shared papers)Vincenzo De Francesco (12 shared papers)A. Francavilla (20 shared papers)Osvaldo Burattini (6 shared papers)V. Stoppino (5 shared papers)
Journals: Digestive and Liver Disease (10 papers)Alimentary Pharmacology & Therapeutics (7 papers)Scientific Reports (2 papers)Digestive Diseases and Sciences (2 papers)Immunopharmacology and Immunotoxicology (2 papers)
Partner nations: Italy Spain United States

In The Last Decade

C. Pañella

46 papers receiving 1.2k citations

Peers

Countries citing papers authored by C. Pañella

Since Specialization

Citations

This map shows the geographic impact of C. Pañella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Pañella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Pañella more than expected).

Fields of papers citing papers by C. Pañella

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Pañella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Pañella. The network helps show where C. Pañella may publish in the future.

Co-authors

The 25 scholars most cited alongside C. Pañella, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C. Pañella Line = papers co-authored together C. Pañella links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Clarithromycin-Resistant Genotypes and Eradication of Helicobacter pylori Annals of Internal Medicine ·Vincenzo De Francesco, (unknown), Angelo Zullo, Cesare Hassan, Laura Troiani, Osvaldo Burattini, Federico Stella, (unknown), Francesco Russo, Stefania Marangi, Rosa Monno, V. Stoppino, S. Morini, C. Pañella, Enzo Ierardi	2006	155
2	Phenotypic and genotypic Helicobacter pylori clarithromycin resistance and therapeutic outcome: benefits and limits Journal of Antimicrobial Chemotherapy ·Vincenzo De Francesco, Angelo Zullo, Enzo Ierardi, Floriana Giorgio, Federico Perna, Cesare Hassan, S. Morini, C. Pañella, D. Vaira	2009	94
3	Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure Alimentary Pharmacology & Therapeutics ·Vincenzo De Francesco, Angelo Zullo, M. Margiotta, Stefania Marangi, Osvaldo Burattini, P.B. Berloco, Francesco Russo, M. Barone, Alfredo Di Leo, M.F. Minenna, V. Stoppino, S. Morini, C. Pañella, A. Francavilla, Enzo Ierardi	2004	90
4	Nutritional state and energy balance in cirrhotic patients with or without hypermetabolism☆Multicentre prospective study by the ‘Nutritional Problems in Gastroenterology’ Section of the Italian Society of Gastroenterology (SIGE) Digestive and Liver Disease ·F. Guglielmi, C. Pañella, Andrea Buda, G Budillon, Lorenza Caregaro, Claudia Clerici, D. Conte, Alessandro Federico, Giovanni Battista Gasbarrini, A. Guglielmi	2005	70
5	The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective, randomised study Digestive and Liver Disease ·Vincenzo De Francesco, Angelo Zullo, Cesare Hassan, N. Della Valle, L. Pietrini, M.F. Minenna, S. Winn, Rosa Monno, V. Stoppino, S. Morini, C. Pañella, Enzo Ierardi	2004	70
6	Total parenteral nutrition-related gastroenterological complications Digestive and Liver Disease ·F.W. Guglielmi, D. Boggio‐Bertinet, Alessandro Federico, Giovanna Forte, A. Guglielmi, C. Loguercio, S. Mazzuoli, Manuela Merli, A Palmo, C. Pañella, Loris Pironi, A. Francavilla	2006	68
7	Oral tacrolimus long‐term therapy in patients with Crohn’s disease and steroid resistance Alimentary Pharmacology & Therapeutics ·Enzo Ierardi, Mariabeatrice Principi, Ruggiero Francavilla, A Pisani, Maria Rendina, Matilde Ingrosso, F.W. Guglielmi, C. Pañella, A. Francavilla	2001	61
8	Two new treatment regimens for Helicobacter pylori eradication: a randomised study Digestive and Liver Disease ·Vincenzo De Francesco, Angelo Zullo, Cesare Hassan, D. Faleo, Enzo Ierardi, C. Pañella, S. Morini	2001	51
9	Long-Term Results of Single-Anastomosis Duodeno-ileal Bypass with Sleeve Gastrectomy (SADI-S) Obesity Surgery ·Andrés Sánchez-Pernaute, Miguel A. Rubio, Natalia Pérez Ferre, Carlos Rodrı́guez, Clara Marcuello, C. Pañella, L López Antoñanzas, Antonio Torres, Elia Pérez-Aguirre	2022	49
10	Proliferative activity of gastric epithelium in progressive stages ofHelicobacter pylori infection Digestive Diseases and Sciences ·C. Pañella, Enzo Ierardi, Lorenzo Polimeno, T. Balzano, Matilde Ingrosso, A. Amoruso, Andrea Traversa, A. Francavilla	1996	40
11	Sequential treatment for Helicobacter pylori eradication in duodenal ulcer patients: improving the cost of pharmacotherapy Alimentary Pharmacology & Therapeutics ·Cesare Hassan, Vincenzo De Francesco, Angelo Zullo, Giuseppe Scaccianoce, D. Piglionica, Enzo Ierardi, C. Pañella, S. Morini	2003	37
12	Quadruple therapy with lactoferrin for Helicobacter pylori eradication: A randomised, multicentre study Digestive and Liver Disease ·Angelo Zullo, Vincenzo De Francesco, Giuseppe Scaccianoce, Cesare Hassan, A. Panarese, D. Piglionica, C. Pañella, S. Morini, Enzo Ierardi	2005	37
13	Modulation of rat hepatocyte proliferation by bile salts: In vitro and In vivo studies Hepatology ·M. Barone, Antonella Bianca Francavilla, Lorenzo Polimeno, Enzo Ierardi, Domenica Romanelli, P.B. Berloco, Alfredo Di Leo, C. Pañella	1996	36
14	Claritromycin resistance and Helicobacter pylori genotypes in Italy. PubMed ·D M Francesco, M. Margiotta, Angelo Zullo, Cesare Hassan, N. Della Valle, Osvaldo Burattini, Rosalia D’Angelo, G. Stoppino, U. Cea, Floriana Giorgio, Rosa Monno, S. Morini, C. Pañella, Enzo Ierardi	2006	34
15	Tumour necrosis factor alpha down-regulation parallels inflammatory regression in ulcerative colitis patients treated with infliximab Digestive and Liver Disease ·Cesare Hassan, Enzo Ierardi, Osvaldo Burattini, Vincenzo De Francesco, Angelo Zullo, G. Stoppino, C. Pañella, S. Morini	2007	32
16	Effectiveness and pharmaceutical cost of sequential treatment for Helicobacter pylori in patients with non‐ulcer dyspepsia Alimentary Pharmacology & Therapeutics ·Vincenzo De Francesco, Nicola Della Valle, V. Stoppino, A. Amoruso, Nicola Muscatiello, C. Pañella, Enzo Ierardi	2004	30
17	Epithelial cell proliferation of the colonic mucosa in diverticular disease: a case–control study Alimentary Pharmacology & Therapeutics ·S. Morini, Cesare Hassan, Angelo Zullo, Vincenzo De Francesco, Osvaldo Burattini, M. Margiotta, C. Pañella, Enzo Ierardi	2005	29
18	DNA sequences and proteic antigens of H. pylori in cholecystic bile and tissue of patients with gallstones Alimentary Pharmacology & Therapeutics ·Vincenzo Neri, M. Margiotta, Vincenzo De Francesco, Antonio Ambrosi, N. Della Valle, Alberto Fersini, Nicola Tartaglia, M.F. Minenna, C. Ricciardelli, Floriana Giorgio, C. Pañella, Enzo Ierardi	2005	29
19	Lupus Nephritis Improvement After Anti‐tumor Necrosis Factor Alpha Monoclonal Antibody (Infliximab) Treatment for Crohn's Disease: A Case Report Immunopharmacology and Immunotoxicology ·Mariabeatrice Principi, Alfredo Di Leo, Matilde Ingrosso, A Pisani, Stefania Marangi, A. Amoruso, C. Pañella, A. Francavilla, Enzo Ierardi	2004	24
20	Irreversible electroporation of the liver: is there a safe limit to the ablation volume? Scientific Reports ·Patricia Sánchez‐Velázquez, Quim Castellví, Alberto Villanueva, Rita Quesada, C. Pañella, Marta Cáceres, Dimitri Dorcaratto, Anna Andaluz, Xavier Moll, Macarena Trujillo, José M. Burdío, Enrique Berjano, Luís Grande, Antoni Ivorra, Fernando Burdı́o	2016	19

About C. Pañella

C. Pañella is a scholar working on Gastroenterology, Small Animals, Surgery, Hepatology and Pulmonary and Respiratory Medicine, having authored 47 papers that have together received 1.2k indexed citations. Recurring topics across this work include Helicobacter pylori-related gastroenterology studies (13 papers), Gastric Cancer Management and Outcomes (7 papers), Veterinary medicine and infectious diseases (5 papers), Clinical Nutrition and Gastroenterology (5 papers), Liver Disease Diagnosis and Treatment (5 papers), Gastroesophageal reflux and treatments (5 papers), Inflammatory Bowel Disease (4 papers) and Diverticular Disease and Complications (3 papers). The work is most often cited by research in Gastroenterology (312 citations), Small Animals (267 citations), Surgery (878 citations), Hepatology (120 citations) and Pulmonary and Respiratory Medicine (346 citations). C. Pañella has collaborated with scholars based in Italy, Spain and United States. Frequent co-authors include Enzo Ierardi, Angelo Zullo, S. Morini, Cesare Hassan, Vincenzo De Francesco, A. Francavilla, Osvaldo Burattini, V. Stoppino, Stefania Marangi and Rosa Monno. Their work appears in journals such as Digestive and Liver Disease, Alimentary Pharmacology & Therapeutics, Scientific Reports, Digestive Diseases and Sciences and Immunopharmacology and Immunotoxicology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact